Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberto Pallini

Showing results (71-80 of 153) with videos related to

Pageof 16
Sort By:
Oncotarget|January 14, 2017
RYK promotes the stemness of glioblastoma cells via the WNT/ β-catenin pathwayAssunta Adamo, Danilo Fiore, Fabio De Martino, et al.
Plos One|February 12, 2009
Tumorigenic potential of olfactory bulb-derived human adult neural stem cells associates with activation of TERT and NOTCH1Patrizia Casalbore, Manuela Budoni, Lucia Ricci-Vitiani, et al.
BMC Cancer|May 12, 2018
VEGF-121 plasma level as biomarker for response to anti-angiogenetic therapy in recurrent glioblastomaMaurizio Martini, Ivana de Pascalis, Quintino Giorgio D'Alessandris, et al.
Neoplasia (New York, N.Y.)|January 14, 2012
Expression of EGFRvIII in glioblastoma: prognostic significance revisitedNicola Montano, Tonia Cenci, Maurizio Martini, et al.
Cancers|December 22, 2019
Brain Invasion along Perivascular Spaces by Glioma Cells: Relationship with Blood-Brain BarrierSimone Pacioni, Quintino Giorgio D'Alessandris, Mariachiara Buccarelli, et al.
Molecular Oncology|March 2, 2017
A three-microRNA signature identifies two subtypes of glioblastoma patients with different clinical outcomesGiovanna Marziali, Mariachiara Buccarelli, Alessandro Giuliani, et al.
Acta Neurochirurgica|October 12, 2018
Eight-year survival of a recurrent glioblastoma patient treated with molecularly tailored therapy: a case reportQuintino Giorgio D'Alessandris, Nicola Montano, Maurizio Martini, et al.
Expert Reviews in Molecular Medicine|March 15, 2023
Telomerase inhibition in malignant gliomas: a systematic reviewQuintino Giorgio D'Alessandris, Marco Battistelli, Giovanni Pennisi, et al.
International Journal of Molecular Sciences|October 14, 2022
Dissecting Stemness in Aggressive Intracranial Meningiomas: Prognostic Role of SOX2 ExpressionRina Di Bonaventura, Maurizio Martini, Tonia Cenci, et al.
Biomolecules|August 26, 2022
Glioblastoma Stem-Like Cells (GSCs) with Mesenchymal Signature: Lipid Profiles of Mobile Lipids Obtained with MRS before and after Radio/Chemical TreatmentsSveva Grande, Alessandra Palma, Anna Maria Luciani, et al.
Pageof 16

Showing results (71-80 of 153) with videos related to

Sort By:
Pageof 16
Oncotarget|January 14, 2017
RYK promotes the stemness of glioblastoma cells via the WNT/ β-catenin pathwayAssunta Adamo, Danilo Fiore, Fabio De Martino, et al.
Plos One|February 12, 2009
Tumorigenic potential of olfactory bulb-derived human adult neural stem cells associates with activation of TERT and NOTCH1Patrizia Casalbore, Manuela Budoni, Lucia Ricci-Vitiani, et al.
BMC Cancer|May 12, 2018
VEGF-121 plasma level as biomarker for response to anti-angiogenetic therapy in recurrent glioblastomaMaurizio Martini, Ivana de Pascalis, Quintino Giorgio D'Alessandris, et al.
Neoplasia (New York, N.Y.)|January 14, 2012
Expression of EGFRvIII in glioblastoma: prognostic significance revisitedNicola Montano, Tonia Cenci, Maurizio Martini, et al.
Cancers|December 22, 2019
Brain Invasion along Perivascular Spaces by Glioma Cells: Relationship with Blood-Brain BarrierSimone Pacioni, Quintino Giorgio D'Alessandris, Mariachiara Buccarelli, et al.
Molecular Oncology|March 2, 2017
A three-microRNA signature identifies two subtypes of glioblastoma patients with different clinical outcomesGiovanna Marziali, Mariachiara Buccarelli, Alessandro Giuliani, et al.
Acta Neurochirurgica|October 12, 2018
Eight-year survival of a recurrent glioblastoma patient treated with molecularly tailored therapy: a case reportQuintino Giorgio D'Alessandris, Nicola Montano, Maurizio Martini, et al.
Expert Reviews in Molecular Medicine|March 15, 2023
Telomerase inhibition in malignant gliomas: a systematic reviewQuintino Giorgio D'Alessandris, Marco Battistelli, Giovanni Pennisi, et al.
International Journal of Molecular Sciences|October 14, 2022
Dissecting Stemness in Aggressive Intracranial Meningiomas: Prognostic Role of SOX2 ExpressionRina Di Bonaventura, Maurizio Martini, Tonia Cenci, et al.
Biomolecules|August 26, 2022
Glioblastoma Stem-Like Cells (GSCs) with Mesenchymal Signature: Lipid Profiles of Mobile Lipids Obtained with MRS before and after Radio/Chemical TreatmentsSveva Grande, Alessandra Palma, Anna Maria Luciani, et al.
Pageof 16